Skip to main content

Table 2 Patients' baseline parameters

From: Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial

Parameter

Value

Age (years)

60 (52–63)

Child–Pugh score

13 (10–14)

Serum creatinine (μmol l-1)

301 (168–451)

INR

1.5 (1.4–2.3)

Bilirubin (μmol l-1)

92 (26–329)

MELD score

23 (15–34)

Serum sodium (mmol l-1)

130 (126–136)

Serum albumin (g dl-1)

27 (18–29)

ASAT (U l-1)

103 (68–183)

ALAT (U l-1)

63 (35–91)

Haemoglobin (g dl-1)

9.4 (7.6–10.2)

MAP (mmHg)

79 (70–96)

CVP (mmHg)

9 (6–12)

GEDVI (ml m-2)

760 (717–906)

SVRI (dyn s cm-5 m-2)

1,394 (1,161–2,037)

Cardiac index (l min-1 m-2)

4.1 (3.2–4.4)

  1. Data are presented as median (25th to 75th centile). INR, International Normalized Ratio; MELD, Model of End-Stage Liver Disease; ASAT, aspartate aminotransferase; ALAT, alanine aminotransferase; MAP, mean arterial pressure; CVP, central venous pressure; GEDVI, global end-diastolic volume index; SVRI, systemic vascular resistance index.